Cybin Inc
CYBN6.070USD
+0.120+2.02%
收盘 11/06, 16:00（美东）报价延迟15分钟
139.81M总市值
亏损市盈率 TTM
关于 Cybin Inc 公司
Cybin Inc. 是一家总部位于加拿大的临床阶段生物制药公司。该公司开发基于迷幻药的疗法，以满足患有精神疾病的人对治疗方案的未满足需求。其 N,N-二甲基色胺 (DMT) 和 dDMT 项目创建了对这些迷幻分子进行系统研究的数据集。该公司正在开发 CYB003（一种用于治疗重度抑郁症的专有氘代裸盖菇素类似物）和 CYB004（一种用于治疗广泛性焦虑症的专有氘代 dDMT 分子），并拥有一系列基于迷幻药的在研化合物。CYB003 进入第三阶段，CYB004 进入第二阶段。它在迷幻药开发领域拥有知识产权组合，已获得 30 多项专利，还有 160 项专利正在申请中。该公司在加拿大、美国、英国、荷兰和爱尔兰开展业务。
Cybin Inc简介
公司代码CYBN
公司名称Cybin Inc
上市日期Jan 05, 2018
CEOMr. Eric How-Lun So
员工数量50
证券类型Ordinary Share
年结日Jan 05
公司地址100 King Street West
城市TORONTO
上市交易所Aequitas NEO-L
国家Canada
邮编M5X 1C9
电话19087648385
网址https://www.cybin.com
公司代码CYBN
上市日期Jan 05, 2018
CEOMr. Eric How-Lun So
Cybin Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Alex Nivorozhkin
Mr. Alex Nivorozhkin
Chief Scientific Officer
Chief Scientific Officer
5.25M
+5.65%
Mr. Gabriel Fahel
Mr. Gabriel Fahel
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
405.35K
+0.54%
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Executive Chairman of the Board, President, Interim Chief Executive Officer
Executive Chairman of the Board, President, Interim Chief Executive Officer
311.12K
-97.41%
Mr. Paul Glavine
Mr. Paul Glavine
Director, Chief Growth Officer
Director, Chief Growth Officer
299.67K
-97.37%
Ms. Theresa Firestone
Ms. Theresa Firestone
Lead Independent Director
Lead Independent Director
1.06K
-97.37%
Mr. Grant B. Froese
Mr. Grant B. Froese
Independent Director
Independent Director
--
--
Mr. Greg Cavers
Mr. Greg Cavers
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Lawson
Mr. Mark Lawson
Independent Director
Independent Director
--
--
Mr. Aaron Bartlone
Mr. Aaron Bartlone
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Eric Hoskins
Dr. Eric Hoskins
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Alex Nivorozhkin
Mr. Alex Nivorozhkin
Chief Scientific Officer
Chief Scientific Officer
5.25M
+5.65%
Mr. Gabriel Fahel
Mr. Gabriel Fahel
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
405.35K
+0.54%
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Executive Chairman of the Board, President, Interim Chief Executive Officer
Executive Chairman of the Board, President, Interim Chief Executive Officer
311.12K
-97.41%
Mr. Paul Glavine
Mr. Paul Glavine
Director, Chief Growth Officer
Director, Chief Growth Officer
299.67K
-97.37%
Ms. Theresa Firestone
Ms. Theresa Firestone
Lead Independent Director
Lead Independent Director
1.06K
-97.37%
Mr. Grant B. Froese
Mr. Grant B. Froese
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 10月25日 周六
更新时间: 10月25日 周六
持股股东
股东类型
持股股东
持股股东
占比
Nivorozhkin (Alex)
19.01%
Tang Capital Management, LLC
6.63%
Point72 Asset Management, L.P.
5.82%
Global X Investments Canada Inc.
4.85%
Tziras (George)
4.69%
其他
59.01%
持股股东
持股股东
占比
Nivorozhkin (Alex)
19.01%
Tang Capital Management, LLC
6.63%
Point72 Asset Management, L.P.
5.82%
Global X Investments Canada Inc.
4.85%
Tziras (George)
4.69%
其他
59.01%
股东类型
持股股东
占比
Individual Investor
31.63%
Hedge Fund
21.19%
Investment Advisor
6.79%
Investment Advisor/Hedge Fund
5.13%
Private Equity
0.41%
Research Firm
0.32%
Bank and Trust
0.05%
其他
34.47%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
186
9.89M
36.92%
-76.12M
2025Q2
203
58.05M
152.46%
-77.16M
2025Q1
209
57.54M
286.29%
-78.15M
2024Q4
205
59.72M
283.54%
-81.34M
2024Q3
197
62.29M
285.74%
-324.75M
2024Q2
204
344.93M
166.65%
-48.46M
2024Q1
195
368.84M
163.99%
+249.67M
2023Q4
177
108.66M
110.45%
+25.70M
2023Q3
166
58.71M
23.51%
+14.44M
2023Q2
156
50.00M
26.24%
+942.60K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Nivorozhkin (Alex)
5.25M
20.85%
+280.74K
+5.65%
Mar 31, 2024
Tang Capital Management, LLC
1.83M
7.27%
--
--
Jun 30, 2025
Point72 Asset Management, L.P.
1.61M
6.38%
+280.13K
+21.12%
Jun 30, 2025
Global X Investments Canada Inc.
1.34M
5.32%
-213.08K
-13.73%
Feb 29, 2024
Tziras (George)
1.29M
5.14%
--
--
Jul 24, 2024
Deep Track Capital LP
1.53M
6.07%
--
--
Jun 30, 2025
Bartlone (Aaron Frank)
901.07K
4.51%
+200.00K
+28.53%
Jun 28, 2024
Rosalind Advisors, Inc.
810.92K
3.22%
--
--
Jun 30, 2025
Acorn Capital Advisors, LLC
734.39K
2.92%
--
--
Jun 30, 2025
Fahel (Gabriel)
405.35K
1.61%
+2.17K
+0.54%
Sep 02, 2025
查看更多
持股ETF
更新时间: 20 小时前
更新时间: 20 小时前
机构名称
占比
AdvisorShares Psychedelics ETF
4.97%
iShares Biotechnology ETF
0.01%
Simplify Propel Opportunities ETF
0%
AdvisorShares Psychedelics ETF
占比4.97%
iShares Biotechnology ETF
占比0.01%
Simplify Propel Opportunities ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Aug 28, 2024
Merger
38→1
Aug 28, 2024
Merger
38→1
Aug 28, 2024
Merger
38→1
Aug 28, 2024
Merger
38→1
公告日期
类型
比率
Aug 28, 2024
Merger
38→1
Aug 28, 2024
Merger
38→1
Aug 28, 2024
Merger
38→1
Aug 28, 2024
Merger
38→1
